GB1210557A - Synthesis of polypeptides containing cysteine - Google Patents
Synthesis of polypeptides containing cysteineInfo
- Publication number
- GB1210557A GB1210557A GB1546968A GB1546968A GB1210557A GB 1210557 A GB1210557 A GB 1210557A GB 1546968 A GB1546968 A GB 1546968A GB 1546968 A GB1546968 A GB 1546968A GB 1210557 A GB1210557 A GB 1210557A
- Authority
- GB
- United Kingdom
- Prior art keywords
- cys
- gly
- leu
- val
- ome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/067—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for sulfur-containing functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1,210,557. Disulphide peptides. FARBENFABRIKEN BAYER A.G. 1 April, 1968 [1 April, 1967; 5 Jan., 1968], No. 15469/68. Heading C2C. Single chain polypeptides with at least one cysteine residue are prepared by (1) synthesis of a first symmetrical cystinyl peptide consisting of 2 identical amino acid sequences corresponding to one portion of the desired single chain peptide linked by at least one -S-S- bond by incorporating a cystine residue at at least one point where the cysteine residue occurs in the desired peptide; (2) preparing a di- or polymeric intermediate consisting of two or more of the desired polypeptide chains linked by at least one cistinyl -S-S- bond by (a) coupling a second symmetrical cystinyl peptide consisting of 2 amino acid sequences corresponding to the remaining portion of the desired single chain polypeptide with the first symmetrical peptide to give a polymeric intermediate consisting of a number of the desired polypeptide chains linked by cystinyl -S-S- bands; or (b) coupling a single chain consisting of an amino acid sequence corresponding to the remaining portion of the desired single chain polypeptide with the first symmetrical peptide to give a dimeric intermediate consisting of 2 of the desired polypeptide chains linked by at least one cystinyl -S-S- bond; and (3) splitting the -S-S- bonds of the intermediate. The synthesis of insulin by the above method is described and intermediates isolated are (Z - Cys - Gly - OMe) 2 ; (Z - Leu - Cys - Gly- OMe) 2 ; (Z - His - Leu - Cys - Gly - OMe) 2 ; (Z - Gln - His - Leu - Cys - Gly - OMe) 2 ; (ZAsn - Gln - His - Leu - Cys- Gly - OMe)2; (Z - Val - Asn - Gln - His - Leu - Cys - Gly- OMe) 4 ; (Z - Phe - Val - Asn - Gln - His - Leu- Cys - Gly OMe) 2 ; (Z - Phe - Val - Asn - Gln- His - Leu - Cys - Gly - N 2 H 3 ) 2 ; Z - Ser(But)- His - Leu - Val - Glu(OBut) - N 2 H 3 ; Z - Ser (But) - His - Leu - Val - Glu(OBut) - Ala - Leu- Tyr(But) - OMe; (Z - Val - Cys - Gly - OMe) 2 ; (Z - Leu - Val - Cys - Gly - OMe) 2 ; (Tri - Leu- Val - Cys - Gly - OMe) 2 ; (Tri - Leu - Val - Cys- Gly - OH) 2 ; (Tri - Leu - Val - Cys - Gly- N 2 H 3 ) 2 ; (Tri - Leu - Val - Cys - Gly - Glu (OBut) - Arg - Gly - OH) 2 ; (Tri - Leu - Val- Cys - Gly - Glu(OBut) - Arg - Gly - Phe - Phe- Tyr(But) - Thr(But) - Pro - Lys(BOC) - Ala- OBut) 2 ; (Z - Phe - Val - Asn - Gln - His Leu- Cys - Gly - Ser(But) - His - Leu - Val - Glu (OBut) - Ala - Leu - Tyr(But) - OMe) 2 ; (Z - Cys- Ala - Gly - OMe) 2 ; (BOC - Cys(TR1) - Cys- Ala - Gly - OMe) 2 ; (BOC - Gln - Cys(TR1) - Cys- Ala - Gly - OMe) 2 ; (BOC - Gly - Ile - Val- Glu(OBut) - Gln - Cys(TRl) - Cys - Ala - Gly- OMe) 2 ; (BOC - Gly - Ile - Val - Glu(OBut). Gin - Cys(TRl) - Cys - Ala - Gly - N 2 H 3 ) 2 (BOC - Cys - ONp) 2 ; (BOC - Cys - Asn - OBz) 2 ; (BOC - Tyr(Bz) - Cys - Asn - OBz) 2 ; (BOCAsn - Tyr(Bz) - Cys - Asn - OBz) 2 ; (BOCGlu(OBz) - Asn - Tyr(Bz) - Cys - Asn - OBz) 2 ; (Trl - Leu - Tyr(But) - Gln - Leu - Glu(OBz)- Asn - Tyr(Bz) - Cys - Asn - OBz) 2 ; and (TR1- Val - Cys(TR1) - Ser- Leu - Tyr - Gln - Leu- Glu(OBz) - Asn - Tyr(Bz) - Cys - Asn - OBz) 2 .
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEF0052000 | 1967-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1210557A true GB1210557A (en) | 1970-10-28 |
Family
ID=7105092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1546968A Expired GB1210557A (en) | 1967-04-01 | 1968-04-01 | Synthesis of polypeptides containing cysteine |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE713055A (en) |
CH (1) | CH507207A (en) |
DE (1) | DE1593866A1 (en) |
FR (1) | FR1573151A (en) |
GB (1) | GB1210557A (en) |
NL (1) | NL6803646A (en) |
-
1967
- 1967-04-01 DE DE19671593866 patent/DE1593866A1/en active Pending
-
1968
- 1968-02-23 CH CH264568A patent/CH507207A/en not_active IP Right Cessation
- 1968-03-14 NL NL6803646A patent/NL6803646A/xx unknown
- 1968-04-01 BE BE713055D patent/BE713055A/xx unknown
- 1968-04-01 FR FR1573151D patent/FR1573151A/fr not_active Expired
- 1968-04-01 GB GB1546968A patent/GB1210557A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE713055A (en) | 1968-10-01 |
FR1573151A (en) | 1969-07-04 |
DE1593866A1 (en) | 1971-02-25 |
NL6803646A (en) | 1968-10-02 |
CH507207A (en) | 1971-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO174351C (en) | Process for producing human insulin precursor, as well as DNA sequence and vector for use of the method | |
GB1527252A (en) | Cyclization of peptides via cystine linkages | |
GB1524747A (en) | Polypeptide | |
GB1524212A (en) | Synthesis of salmon calcitonin | |
WETZEL et al. | Properties of a human alpha-interferon purified from E. coli extracts | |
GB1498048A (en) | Decapeptide amides | |
GB1516947A (en) | Hentricontapeptides | |
NO913232D0 (en) | NEW Platelet-Derived Growth Factor-B CHAIN ANALOGS AND METHOD FOR HOMOGENIC PRODUCTION OF THESE. | |
GB1003683A (en) | New polypeptides and process for their manufacture | |
GB1440859A (en) | Vasopressin-type hormones and a method for their preparation | |
GB1453454A (en) | Process for the manufacture of insulin analogues and derivatives thereof | |
GB1464774A (en) | 13-l-norleucine-14-desamido-motilin a method for preparing it and a therapeutic containing it | |
PT78979A (en) | PREPARATION OF POLYPEPTIDES WITH A SAEUREAMIDE CARBOXYTERMIN | |
ATE79409T1 (en) | MANUFACTURING PROCESS FOR HUMAN ATRIAL NATRIURETIC POLYPEPTIDE. | |
GB1464630A (en) | Human proinsulin c-peptide derivatives | |
GB1526367A (en) | Polypeptide | |
GB1210557A (en) | Synthesis of polypeptides containing cysteine | |
GB1437477A (en) | Synthetic peptides | |
ES2044928T3 (en) | ALPHA-AMIDANT ENZYME IN TERMINAL C AND PROCEDURE FOR THE PRODUCTION AND USE OF THE SAME. | |
GB1477002A (en) | Peptides | |
GB1429251A (en) | Synthesis of polypeptides | |
GB1259017A (en) | ||
GB1308809A (en) | D-analogs of secretin | |
GB1470809A (en) | Method of producing peptides having a high adrenocorticotropic effect | |
GB1268463A (en) | Improved process for making peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLNP | Patent lapsed through nonpayment of renewal fees |